Thank you for submitting your manuscript entitled 'The thermogenic coactivator PGC-1β is a target of the ER-resident E3 ligase synoviolin in energy expenditure'. I have now received reports from all referees, which are enclosed below.
Thank you for the opportunity to consider your work for publication. I look forward to your revision.
------------------------------------------------REFEREE COMMENTS
Referee #1:
Title: The thermogenic coactivator PGC-1β is a target of the ER-resident E3 ligase synoviolin in energy expenditure.
In this report the authors comprehensively demonstrated that synoviolin deficiency results in weight loss due to a lower accumulation of white adipose tissue. The authors utilized three different animal models in their studies to evaluate the effect Syn1 has on weight, and to determine the mechanism in which weight is regulated in these models. This is a valuable study that suggests a new potential therapeutic target to treat obesity; however several concerns need to be addressed.
Major Concerns: Overall, several the main critical concerns is that 1) how much of the increased respiratory phenotype functions through PGC1b in white adipose cells. Along these lines it would be necessary to deplete PGC1b within the context of synoviolin KO or depleted adipose cells. This is important as PGC1b is also highly expressed in BAT, heart and skeletal muscle. 2) Does the synoviolin inhibitor works in KO mice? Does it induce PGC1b? 3) It is not clear the rationale of why the authors jump into PGC1beta, was there any unbiased attempt?
Additional concerns: 1. Figure 4F and Expanded View Fig. E2D ; Authors should include a merged image of -FLAG, -HA, and nuclear staining if the conclusion is that co-localization is either occurring or not.
2. There appears to be some inconsistencies in the banding pattern between western blots that are blotting for the same proteins ie. Figure 4A blot 2 and 4B. Additionally in Figure 4A , it appears the blot was cut short at the top so it is difficult to see the PGC1B band. The authors should include a larger portion of the blots and include band sizes.
3. Authors state for both Figures 1 and 2 that the differences in body weight were not due to any differences in food intake, yet the data in figure one demonstrates a significant difference at day 14 and the data in figure two demonstrates a significant difference at day 2-3. Authors should add a comment that includes "No differences in food intake were noted across groups at time points that resulted in significant weight loss." 4. Authors describe several studies that were performed in tissue culture as "in vivo." This description should be reserved for experiments done using the mouse models, not tissue culture.
5. Page 8, line 162; there is a double comma after HEK293 cells,,... 6. Page 11, line 233; Delete "in" in the following sentence. "Moreover, mitochondrial respiration and activity in were... 7. Materials and Methods, Mice; Please include the type of diet and housing conditions for the mice.
8. Figure 1B ; the word "deleted" is misspelled.
9. Figure 3A ; the word "deleted" is misspelled.
10. Figure 5H ; even though the control values have been set to 100, error bars should still be included.
11. Figure 6F ; include scale bars in both images. Additionally, authors may want to verify that magnifications are the same for both images.
Referee #2:
In their manuscript "The thermogenic coactivator PGC-1β is a target of the ER-resident E3 ligase synoviolin in energy expenditure" Fujita et al. address the role of synoviolin in obesity and depict PGC-1β as a target of synoviolin. First, Fujita and colleagues generated conditional synoviolin (SYVN1) knockout mice. They demonstrated that a reduction of SYVN1 level in the generated mice and different mouse models of obesity result in a reduced gain of body weight within time compared to control lines. Furthermore, the authors showed that a specific reduction of SYVN1 in WAT tissue reduces the augmentation of body weight in different mouse models. Next, Fujita and colleagues exhibited that SYVN1 could directly interact with PGC-1β via its SyU domain. Moreover, SYVN1 appears to be important for the ubiquitination and stabilization of PGC-1β as well as mitochondrial biogenesis and function. Injection of SYVN1 inhibitors in different mouse models resulted in reduced ubiquitination of PGC-1β, gain of body weight, lipid droplet formation and blood glucose level compared to control lines. The data shown in this manuscript implies a role of synoviolin in white adipose tissue accumulation through the regulation of PGC-1β stabilization, which represents a process that has not been linked to obesity so far. The identified relationship of synoviolin and PGC-1β to obesity is intriguing and will attract general attention of a broad readership. However, some parts of the represented experiments do not allow a final interpretation of the data. Thus, the manuscript requires improvement of the following points before publication.
Comments:
1) The authors demonstrated that PGC-1β is a substrate of SYVN1 and concluded that the reduced gain of body weight associated with SYVN1 down regulation or inhibition is caused by improved PGC-1β activity. Is this loss in body weight indeed PGC-1β dependent or are there other substrates regulated by SYVN1? Given the authors interpretation, down regulation of both PGC-1β and SYVN1 should convert this effect, which should be done to prove the central statement of the manuscript. 2) Has the conditional knockout of synoviolin a general effect on the health of the mice? Do they have a reduced lifespan and die earlier? 3) Fig 1E) The authors wrote in the figure legend: "Changes in body weight. *P < 0.05, **P < 0.01 for Tam-treated CAG-Cre-ER; Syvn1flox/flox mice vs. other genotypes". It is however not sufficient to refer to "other genotypes" in the legend. Especially for those who are not familiar with the genetic nomenclature it is important to describe the mouse strains exactly for correct interpretation of the data. Fig2 A) A reduction of SYVN1 in ob/ob and db/db mice limits their gain of body weight during time. Interestingly, the authors showed that ob/ob mice have increased SYVN1 level. It would be important to clarify whether the expression of SYVN1 is altered in db/db mice.
4)

5) Fig 2 C/F)
For non experts it is difficult to detect the differences in the indicated mouse tissues. It would be important to dissect the tissues and to weight them like it was done for Fig1. Fig 3A) The authors created a specific knockout of SYVN1 in WAT tissue in the mouse models. The authors confirmed the SYVN1 deletion by PCR, producing different bands for the gene deletion and the wild-typ version. Why does the SYVN1 knockout tissue still show the wild-typ gene product? 7) FigE2B) Does the band at the bottom represent the loading control? If this is the case, the authors should clearly label and describe it both in the figure and corresponding legend.
6)
8) Fig4E)
The authors suggested that HA-PGC-1β interacts directly with SYVN1/FLAG in vivo using co-immunoprecipitation assays. However, the control line is overexposed in the blot and does not allow a clear interpretation of the data. These IPs should be repeated. 9) Fig4E) Co-immunoprecipitation assays in cell culture are still in cellulo and not in vivo. The authors should use mouse material to show the interaction between SYVN1 and PGC-1β in vivo. 10) Fig 4F) The authors concluded that SYVN1 traps PGC-1β around the nucleus using cotransfection assays in cell culture. However, the shown pictures do not convincingly confirm this hypothesis. The authors should provide a better resolution of these pictures. Do all co-transfected cells exhibit the same phenotype/how many of them show this phenotype? 11) Fig 4G/H ) the loading control is missing in both cases. 12) Fig4H) shorter exposure times would make it easier to interpret the data. 14) Fig 5D) The authors claimed that a reduction of SYVN1 in 3T3 L1 cells results in an accumulation of mitochondria compare to control cells. However, the presented pictures do not support this argumentation. The authors should provide a quantification of the mitochondrial number for each condition. Figure 5G shows an increase of mitochondrial size in adipose tissue after down regulation of SYVN1. However, in figure 5D the mitochondria look even smaller upon SYVN1 depletion. The authors should comment on this. Fig 6G) The authors should mark and quantify the mitochondria for better interpretation of the data. >We fully agree to the reviewer's comment.
15) Fig5D/G)
16)
1) how much of the increased respiratory phenotype functions through PGC1b in white adipose
cells. Along these lines it would be necessary to deplete PGC1b within the context of synoviolin KO or depleted adipose cells.
>To address this comment, we investigated the contribution of PGC-1β to mitochondrial function in the condition of SYVN1 knockout by the following two experiments with Ppargc1b siRNAs. First, Ppargc1b was depleted in mouse 3T3L1 pre-adipocytes, as shown in Figure 5D . Syvn1 siRNAtreated cells contained increased numbers of mitochondria compared to those treated with control siRNA. However, this increase (approximately 1.6 times) was restored by the additional treatment with Ppargc1b siRNAs.
Based on this observation, we would like to add the sentence "and the increase was not observed in cells that were co-transfected with both Syvn1 and Ppargc1b siRNAs" at the upper of p.11. Second, we measured respiration levels in pre-adipocytes. The respiration of SYVN1 KO cells was higher than that of WT cells as previously shown, and this increase was also reduced by treatment of Ppargc1b siRNAs (Expanded View Fig. E5C ). Thus, we added the sentence "This higher respiration was also observed in Syvn1 knockout preadipocyte cells compared to Syvn1 WT cells, and the higher respiration was reduced by treatment of Ppargc1b siRNAs in Syvn1 knockout cells (Expanded View Fig. E5C )." at the lower of p.11. In addition, we added the sentence "Pre-adipocyte cells were obtained from CAG-Cre-ER;Syvn1 flox/flox mice. White adipose tissues were minced and incubated with collagenase solution for 45 minutes at 37°C. Then cell suspension was filtered twice. Cells were cultured in DMEM/F12. Cells were treated with DMSO or tamoxifen, and transient transfection of siRNA was performed five days before experiment." at the upper of p22. Furthermore, we added the sentence "C. Mitochondrial respiration was measured in pre-adipocyte cells (the value for WT + control siRNA was set to 100%). The WT and knockout cells were transiently treated with control siRNA or Ppargc1b siRNA. Data were analyzed with the Mann-Whitney U test and represent the mean ± SD (n = 3). *P < 0.05." at the middle of p.3. in Expanded View text. These results indicated that the phenotype of SYVN1 knockout is PGC-1β-dependent. We added the sentence "These results indicated that respiratory phenotype of Syvn1 knockout is PGC1b dependent." at the lower of p.11.
2) Does the synoviolin inhibitor works in KO mice? Does it induce PGC1b?
>To determine the selectivity of synoviolin inhibitor, especially in KO mice, we examined the level of PGC-1β in SYVN1 KO MEFs. As shown in Expanded View Fig. E6 )." at the middle of p12. Furthermore, we added the sentence "Expanded View Figure E6 . LS102 is a selective inhibitor of SYVN1. MEFs derived from Syvn knockout mice (Yamasaki et al, 2007) were treated with DMSO, LS-102 5 µM, or 10µM for 6h, then lysed with buffer (10 mM Tris-HCl, pH 8.0; 150 mM NaCl; 1 mM EDTA; 1% NP-40; 1 mM DTT; and protease inhibitors) and analyzed by immunoblotting with antibodies against PGC-1β or SYVN1. Each experiment was performed at least three times." at the middle of p.3. in Expanded View text.
3) It is not clear the rationale of why the authors jump into PGC1beta, was there any unbiased attempt?
>Thank you for your advice. There are two reasons why to focus on PGC-1β in the present study. First, we carried out microarray analysis using adipose tissue derived from CAG-Cre-ER;Syvn1 flox/flox and Syvn1 flox/flox to understand the dramatic phenotype in SYVN1 KO and found that genes involved in β oxidation and mitochondria biogenesis were increased in KO mice (Expanded View Fig. E3 ). Since it is well known that PPAR family and their coactivators transcriptionally play pivotal roles in peripheral energy expenditure via the control of mitochondrial function and β oxidation, we next analyzed these factors as shown in Figure 4A . We found that PGC-1β is a target for Synoviolin in adipose tissue. We would like to add the sentence "To understand the molecular mechanism, we first used microarray analysis in WAT. Genes involved in β oxidation and mitochondria biogenesis (Expanded View Fig. E3) Figure 4F and Expanded View Fig. E2D ; Authors should include a merged image of -FLAG, -HA, and nuclear staining if the conclusion is that co-localization is either occurring or not.
>Following the reviewer's recommendation, we added the co-localization data in Fig. 4F and E4D . These data clearly showed co-localization of SYVN1 and PGC-1β.
>Following the reviewer's recommendation, we modified the Fig. 4A and B and added band sizes.
Authors state for both Figures 1 and 2 that the differences in body weight were not due to any differences in food intake, yet the data in figure one demonstrates a significant difference at day 14 and the data in figure two demonstrates a significant difference at day 2-Authors should add a comment that includes "No differences in food intake were noted across groups at time points that resulted in significant weight loss."
>Following the reviewer's recommendation, we changed the sentence from "no differences were found in terms of food consumption between CAG-Cre-ER;Syvn1 flox/flox and control mice (Fig. 1G) " to "differences were almost not found in terms of food consumption between CAG-Cre-ER;Syvn1 flox/flox and control mice at day 1 and 7, and higher food consumption was observed in CAG-Cre-ER;Syvn1 flox/flox mice than control mice at day 14 ( Fig. 1G) " at the middle of p.6.
Authors describe several studies that were performed in tissue culture as " in vivo." This description should be reserved for experiments done using the mouse models, not tissue culture.
>Following the reviewer's recommendation, we changed "in vivo" to "in cellulo". We changed the sentence from "To verify the interaction in vivo, HA-PGC-1β and FLAG-tagged SYVN1 (SYVN1/FLAG) were co-transfected into HEK 293T cells." to "To verify the interaction in cellulo, HA-PGC-1β and FLAG-tagged SYVN1 (SYVN1/FLAG) were co-transfected into HEK 293T cells." at the middle of p.8.
Page 8, line 162; there is a double comma after HEK293 cells,,...
>Thank you for your comment. We deleted one comma.
6. Page 11, line 233; Delete "in" in the following sentence. "Moreover, mitochondrial respiration and activity in were... >Thank you for your comment. We deleted "in".
Materials and Methods, Mice; Please include the type of diet and housing conditions for the mice.
>Following the reviewer's recommendation, we added the sentence "Mice were kept in SPF under conditions (20-26°C temperature; 40-65% humidity) on a 12 h light/12 h dark cycle. F-1 Foods (5.1 % fat, 21.3 % protein) were purchased from Funabashi farm (Chiba, Japan)." at the upper of p.16. Figure 1B ; the word "deleted" is misspelled.
8.
>Following the reviewer's recommendation, we changed "deletede" to "deleted" in Fig. 1B. 9. Figure 3A ; the word "deleted" is misspelled.
>Following the reviewer's recommendation, we changed "deletede" to "deleted" in Fig. 3A .
>Following the reviewer's recommendation, we added error bars in Fig. 5H .
>Following the reviewer's recommendation, we added scale bars in Fig. 6F . In addition, we confirmed that magnifications were the same for both images.
Referee #2: >To address this comment, we investigated the contribution of PGC-1β in mitochondria function in the condition of SYVN1 knockout by the following two experiments with Ppargc1b siRNAs. First, Ppargc1b was depleted in mouse 3T3L1 pre-adipocytes, as shown in Figure 5D . Syvn1 siRNA-treated cells contained increased numbers of mitochondria compared to those treated with control siRNA. However, this increase (approximately 1.6 times) was restored by the additional treatment with Ppargc1b siRNAs. Based on this observation, we would like to add the sentence "and the increase was not observed in cells that were co-transfected with both Syvn1 and Ppargc1b siRNAs" at the upper of p.11.
In their manuscript "The thermogenic coactivator PGC-1β is a target of the ER-resident
Second, we measured respiration levels in pre-adipocytes. The respiration of SYVN1 KO cells was higher than that of WT cells as previously shown, and this increase in respiration was also reduced by treatment of Ppargc1b siRNAs (Expanded View Fig. E5C ). Thus, we added the sentence "This higher respiration was also observed in Syvn1 knockout pre-adipocyte cells compared to Syvn1 WT cells, and the higher respiration was reduced by treatment of Ppargc1b siRNAs in Syvn1 knockout cells (Expanded View Fig. E5C )." at the lower of p.11. In addition, we added the sentence "Preadipocyte cells were obtained from CAG-Cre-ER;Syvn1 flox/flox mice. White adipose tissues were minced and incubated with collagenase solution for 45 minutes at 37°C. Then cell suspension was filtered twice. Cells were cultured in DMEM/F12. Cells were treated with DMSO or tamoxifen, and transient transfection of siRNA was performed five days before experiment." at the upper of p22. Furthermore, we added the sentence "C. Mitochondrial respiration was measured in pre-adipocyte cells (the value for WT + control siRNA was set to 100%). The WT and knockout cells were transiently treated with control siRNA or Ppargc1b siRNA. Data were analyzed with the MannWhitney U test and represent the mean ± SD (n = 3). *P < 0.05." at the middle of p.3. in Expanded View text. These results indicated that the phenotype of SYVN1 knockout is PGC-1β-dependent. We added the sentence "These results indicated that the respiratory phenotype of Syvn1 knockout is PGC1b dependent." at the lower of p.11.
2) Has the conditional knockout of synoviolin a general effect on the health of the mice? Do they have a reduced lifespan and die earlier?
>Thank you for your comment. We think conditional knockout of Syvn1 did not have a general effect on the health, because serum biochemical tests showed no significant differences in several biomarkers of nutrition, liver and kidney functions between SYVN1 knockout and WT mice (Expanded View Tables E1). Conditional knockout mice of Syvn1 died earlier than control mice. However, adipose-specific knockout mice (Adipoq-Cre;Syvn1 flox/flox mice) survived and their body weight was significantly decreased (Fig. 3) . We were able to completely separate decrease of body weight from lethality by using Adipoq-Cre;Syvn1 flox/flox mice.
3) Fig 1E) The authors wrote in the figure legend: "Changes in body weight. >Following the reviewer's recommendation, we changed the sentence from "Changes in body weight. *P < 0.05, **P < 0.01 for Tam-treated CAG-Cre-ER;Syvn1 flox/flox mice vs. other genotypes" to "Changes in body weight. *P < 0.05, **P < 0.01 for Tam >Following the reviewer's recommendation, we performed immunoblotting with adipose tissue of db/db mice. The protein expression of SYVN1 was higher in adipose tissue derived from both ob/ob mice and db/db mice than ob/+ and db/+ mice ( Fig. 2A) . We changed the sentence from "The expression level of SYVN1 was higher in ob/ob than in ob/+ mice ( Fig. 2A)" to "The expression level of SYVN1 was higher in ob/ob and db/db than in ob/+ and db/+ mice ( Fig. 2A) ." at the upper of p.7. In addition, we changed the sentence from "SYVN1 expression in the WAT of ob/+ and ob/ob mice." to "SYVN1 expression in the WAT of ob/+, ob/ob, db/+, and db/db mice" at the upper of p.31. Fig1. >Following the reviewer's recommendation, we added the photo of dissected adipose tissue in Expanded View Fig. E2 . We changed the sentence from "An anatomical dissection revealed a
5) Fig 2 C/F) For non experts it is difficult to detect the differences in the indicated mouse tissues. It would be important to dissect the tissues and to weight them like it was done for
